Study of Palasha Pushpa in Managing Vatarakta (Gouty Arthritis)
Journal name: Ayushdhara
Original article title: Clinical Study of Palasha Pushpa (Butea Monosperma (Lam.) Kuntze) in the Management of Vatarakta (Gouty arthritis)
AYUSHDHARA is an international peer-reviewed journal. It focuses on research in Ayurveda, Yoga, Unani, Siddha, Homeopathy, Allopathy, and Pharmaceutical Sciences.
This page presents a generated summary with additional references; See source (below) for actual content.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Gandham Neelima
PG Scholar, Department of Dravyaguna, Dr.BRKR. Govt. Ayurvedic College, Hyderabad, Telangana, India.
V.Narasimha
Assistant Professor, Department of Dravyaguna, Dr.BRKR. Govt. Ayurvedic College, Hyderabad, Telangana, India.
A.Vijaya Lakshmi
Professor & HOD, Department of Dravyaguna, Dr.BRKR. Govt. Ayurvedic College, Hyderabad, Telangana, India.
Ayushdhara:
(A peer-reviewed, bi-monthly open-access journal)
Full text available for: Clinical Study of Palasha Pushpa (Butea Monosperma (Lam.) Kuntze) in the Management of Vatarakta (Gouty arthritis)
Year: 2021 | Doi: 10.47070/ayushdhara.v8i3.750
Copyright (license): CC BY-NC-SA 4.0
Download the PDF file of the original publication
Summary of article contents:
Introduction
This clinical study aimed to evaluate the effectiveness of Palashapushpa churna (powder of Butea monosperma) in treating Vatarakta, commonly known as gouty arthritis. Conducted at the Dr.B.R.K.R Government Ayurvedic Hospital in Hyderabad, the single-blind randomized trial included 30 patients, with a treatment duration of 45 days. The study focused on assessing both subjective symptoms, including pain and swelling, and objective parameters, such as serum uric acid levels. The findings suggest that Palashapushpa churna significantly alleviated the symptoms and reduced uric acid levels in patients diagnosed with Vatarakta.
Efficacy of Palashapushpa in Symptom Relief
The study recorded significant improvements in the majority of subjective symptoms associated with Vatarakta. Notably, a 93.33% relief was observed in 'Sula' (pain), 60% in 'Daha' (burning sensation), and 60% in 'Shotha' (swelling). The results indicated that 80% of the patients experienced relief from 'Sthabdata' (stiffness), showcasing Palashapushpa's effectiveness in addressing these symptomatic manifestations of the disease. The assessment also demonstrated that serum uric acid levels decreased significantly from an average of 2.13 mg/dL before treatment to 1.13 mg/dL afterward, with a high statistical significance (P<0.001), corroborating the therapeutic potential of this Ayurvedic formulation.
Factors Influencing the Study Outcomes
The study also examined various demographic factors such as age, gender, occupation, dietary habits, and socio-economic status of the patients. The majority of participants were between the ages of 30 to 40 and equally distributed between genders. Furthermore, most patients reported dietary habits that included mixed diets, with a notable prevalence of alcohol consumption. These factors potentially underscore the lifestyle changes that contribute to the incidence of Vatarakta. Recognizing that dietary intake, particularly the consumption of non-vegetarian foods, is correlated with the severity of gout symptoms, the study emphasizes the importance of dietary management along with herbal treatment for effective patient care.
Conclusion
In conclusion, the clinical trial established that Palashapushpa churna is a potent herbal remedy for managing Vatarakta, providing considerable relief from both subjective symptoms and serum uric acid levels. Despite the promising results, the study acknowledged its limitations due to the small sample size. It advocates for further research involving larger cohorts and various extraction methods of Palashapushpa to better understand its efficacy in treating Vatarakta, which could significantly benefit the population at large by offering a natural therapeutic option for gouty arthritis management.
FAQ section (important questions/answers):
What was the main objective of the clinical study?
The study aimed to evaluate the effectiveness of Palashapushpa churna in managing Vatarakta (Gouty Arthritis) by assessing both subjective symptoms like pain and swelling, and objective measures like serum uric acid levels.
What were the significant results observed in patients?
The study found that 93.33% of patients experienced relief from pain, and serum uric acid levels decreased significantly from an average of 2.13 to 1.13, indicating a positive effect of Palashapushpa churna.
What criteria were used for patient inclusion in the study?
Patients aged 18 to 60 years with diagnosed symptoms of Vatarakta, such as Daha, Ruja, Shotha, and Raga, and serum uric acid levels above 7 mg/dl, were included in the study.
Glossary definitions and references:
Scientific and Ayurvedic Glossary list for “Study of Palasha Pushpa in Managing Vatarakta (Gouty Arthritis)�. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.
1) Vatarakta (Vata-rakta):
Vatarakta is a systemic, metabolic, inflammatory disease that chiefly affects small peripheral joints, such as those in the hands and feet. It is closely correlated with gouty arthritis in modern medicine, characterized by hyperuricaemia and monosodium urate deposits.
2) Sandhi (Shandhi, Samdhi):
Sandhi refers to the joints in the body. In the context of Vatarakta, various symptoms such as Sandhi shula (joint pain), Sandhi shotha (joint swelling), and Sandhi daha (joint burning sensation) are assessed to evaluate the severity and relief of the disease.
3) Disease:
The term 'disease' in this context refers to Vatarakta, a chronic inflammatory disorder. The study focuses on assessing the effectiveness of Palashapushpa churna in managing the disease and alleviating its symptoms.
4) Raga:
Raga refers to the redness or discoloration observed in the affected joints during Vatarakta. This symptom was assessed before and after treatment to evaluate the effectiveness of Palashapushpa churna in providing relief from redness.
5) Drug:
The drug studied here is Palashapushpa churna, an Ayurvedic preparation made from the flower of Butea monosperma. It is used to treat Vatarakta by alleviating symptoms such as joint pain, swelling, and stiffness without significant side effects.
6) Shotha (Sotha):
[see source text or glossary: Sotha]
7) Daha:
Daha refers to a burning sensation in the affected joints, a common symptom of Vatarakta. The study measured the relief from daha after the administration of Palashapushpa churna.
8) Diet:
Diet plays a critical role in managing Vatarakta. Mixed diets, particularly those high in purines like red meat and seafood, can exacerbate symptoms. Patients were advised to follow dietary restrictions to improve treatment outcomes.
9) Palasha (Palasa, Pala-asha):
Palasha, known scientifically as Butea monosperma, is a plant whose flowers were used to prepare the churna tested in this study. The plant is known for its medicinal properties and is effective in relieving symptoms of Vatarakta.
10) Shula (Sula):
[see source text or glossary: Sula]
11) Butea monosperma:
Butea monosperma, also known as Palasha, belongs to the Fabaceae family. It is the primary ingredient in Palashapushpa churna, tested in this study for its effectiveness in managing Vatarakta.
12) Dravyaguna (Dravya-guna):
Dravyaguna is the branch of Ayurveda dealing with the properties, classification, and therapeutic uses of herbs. The study was conducted by the Department of Dravyaguna to evaluate the efficacy of Palashapushpa churna.
13) Pitta:
Pitta is one of the three doshas in Ayurveda, representing metabolic and digestive functions. In Vatarakta, Pitta along with Rakta (blood) can lead to symptoms like inflammation and redness. The treatment aims to balance Pitta.
14) Pushpa (Puspa):
Pushpa means flower in Sanskrit. In this study, Palashapushpa refers to the flower of Butea monosperma used to make the churna for treating Vatarakta.
15) Vata:
Vata is one of the three doshas in Ayurveda, associated with movement and bodily functions. Imbalance in Vata dosha contributes to the symptoms of Vatarakta, such as joint pain and stiffness.
16) Food:
Food, especially those high in purines like seafood and red meat, can aggravate Vatarakta. Dietary modifications were recommended for patients to help manage their symptoms effectively.
17) Ayurveda (Ayus-veda):
Ayurveda is an ancient Indian medical system that emphasizes holistic health and natural remedies. It provides a framework for understanding diseases like Vatarakta and includes treatments like Palashapushpa churna.
18) Kapha:
Kapha is one of the three doshas in Ayurveda, representing structure and lubrication. Imbalances in Kapha, along with Vata and Pitta, are examined in the context of Vatarakta to customize treatment plans.
19) Nighantu (Nighamtu):
Nighantu refers to ancient texts that classify and describe medicinal plants. They provide valuable pharmacological, morphological, and therapeutic information for herbs like Palasha.
20) Vatadosha (Vatadosa, Vata-dosha):
[see source text or glossary: Vatadosha]
21) Gandham:
[see source text or glossary: Gandham]
22) Powder:
In this study, the flowers of Butea monosperma were pulverized into a fine powder, Palashapushpa churna, which was then administered to patients twice daily to treat Vatarakta.
23) Guna:
Guna refers to the qualities or properties of substances. In Ayurveda, different gunas like Ruksha (dry) and Laghu (light) are considered when recommending treatments like Palashapushpa churna.
24) Phytochemical:
Phytochemicals are bioactive compounds found in plants. The study discusses the presence of flavonoids, tannins, and glycosides in Butea monosperma, which have anti-inflammatory and analgesic properties beneficial for treating Vatarakta.
25) Vatapitta (Vata-pitta):
Vata-pitta refers to individuals who have a predominant mix of Vata and Pitta doshas. The study found that Vata-pitta individuals were more affected by Vatarakta, requiring treatments that balance both Vata and Pitta doshas.
26) Kaphavata (Kapha-vata):
Kapha-vata refers to the dual predominance of Kapha and Vata doshas in an individual's constitution. Understanding prakriti, including Kapha-vata tendencies, helps in customizing treatments for diseases like Vatarakta.
27) Prakriti (Prakrti):
Prakriti is the natural constitution of an individual based on the predominance of doshas (Vata, Pitta, Kapha). It helps in understanding susceptibility to diseases like Vatarakta and customizing treatments like Palashapushpa churna.
28) Medicine:
Medicine in this study refers to the Ayurvedic treatment using Palashapushpa churna. It was evaluated for its effectiveness in managing symptoms of Vatarakta without significant side effects.
29) Madhura:
Madhura refers to the sweet taste, which is one of the properties of Palashapushpa. In Ayurveda, Madhura rasa (sweet taste) is considered to have a pacifying effect on Vata and Pitta doshas, making it beneficial for Vatarakta.
30) Dosha (Dosa):
[see source text or glossary: Dosa]
31) Rakta:
[see source text or glossary: Raktha]
32) Dhatu:
[see source text or glossary: Dhatu]
33) Pharmacological:
[see source text or glossary: Pharmacological]
34) Inflammation:
Inflammation is a key symptom of Vatarakta, characterized by swelling, redness, and pain in the joints. The study evaluates Palashapushpa churna's effectiveness in reducing inflammation.
35) Raktadhatu (Rakta-dhatu):
[see source text or glossary: Raktadhatu]
36) Pittadosha (Pittadosa, Pitta-dosha):
Pitta-dosha governs metabolism and transformation in the body. In Vatarakta, Pitta-dosha is involved along with Rakta (blood), leading to inflammation and redness. Treatments aim to balance Pitta-dosha.
37) Discussion:
[see source text or glossary: Discussion]
38) Samhita:
[see source text or glossary: Samhita]
39) Anupana:
Anupana refers to the vehicle or substance taken along with a medication to enhance its effects. In this study, water was used as Anupana for taking Palashapushpa churna.
40) Family:
Family in this context refers to the botanical classification of the plant. Butea monosperma, used in the study, belongs to the Fabaceae family.
41) Tikta:
Tikta means bitter taste in Sanskrit. It is one of the tastes attributed to Palashapushpa. In Ayurveda, Tikta rasa has properties that help in purifying blood and reducing inflammation, making it useful in Vatarakta.
42) India:
India is the country where this study was conducted, specifically at Dr.B.R.K.R. Govt. Ayurvedic College in Hyderabad. Ayurveda, the traditional system of medicine used in this study, originated in India.
43) Veda:
[see source text or glossary: Veda]
44) Rasa (Rasha):
[see source text or glossary: Rasa]
45) Madhurarasa (Madhura-rasa):
[see source text or glossary: Madhura-rasa]
46) Atharvaveda (Atharva-Veda):
[see source text or glossary: Atharvaveda]
47) Tridoshahara (Tridosahara, Tridosha-hara):
Tridosahara refers to substances that balance all three doshas (Vata, Pitta, Kapha). Palashapushpa is described as Tridosahara, making it effective in treating the multifactorial symptoms of Vatarakta.
48) Raktapitta (Rakta-pitta):
[see source text or glossary: Raktapitta]
49) Narasimha (Narasingha, Nara-simha):
[see source text or glossary: Narasimha]
50) Shothahara (Sothahara, Shotha-hara):
Sothahara refers to anti-inflammatory properties. Palashapushpa is described as having Sothahara properties, which help in reducing swelling (shotha) in conditions like Vatarakta.
51) Knowledge:
Knowledge, in this context, refers to the accumulated understanding from Ayurvedic texts and modern research. Both types of knowledge were integrated to evaluate Palashapushpa's effectiveness for Vatarakta.
52) Stiffness:
[see source text or glossary: Stiffness]
53) Prabhava:
[see source text or glossary: Prabhava]
54) Prakasha (Prakasa):
[see source text or glossary: Prakasha]
55) Narahari (Nara-hari):
[see source text or glossary: Narahari]
56) Vatahara (Vata-ahara):
[see source text or glossary: Vatahara]
57) Ashtanga (Astanga, Ashtan-anga):
[see source text or glossary: Ashtanga]
58) Swelling:
[see source text or glossary: Swelling]
59) Pregnant:
[see source text or glossary: Pregnant]
60) Sanskrit:
[see source text or glossary: Sanskrit]
61) Lakshmi (Laksmi):
[see source text or glossary: Lakshmi]
62) Sukshma (Suksma, Shukshma):
[see source text or glossary: Sukshma]
63) Grahani:
[see source text or glossary: Grahani]
64) Prakrit (Prakrt):
[see source text or glossary: Prakrit]
65) Ayushya (Ayusya):
[see source text or glossary: Ayushya]
66) Vyavayi:
[see source text or glossary: Vyavayi]
67) Pandita (Pandit):
[see source text or glossary: Pandita]
68) Dravya:
[see source text or glossary: Dravya]
69) Ruksha (Ruksa):
Ruksha means dry and is one of the qualities (guna) of Palashapushpa. This property contributes to its effectiveness in treating diseases with excessive moisture or inflammation, such as Vatarakta.
70) Vijaya:
[see source text or glossary: Vijaya]
71) Madhya:
[see source text or glossary: Madhya]
72) Vipaka:
[see source text or glossary: Vipaka]
73) Anguli (Amguli):
[see source text or glossary: Anguli]
74) Forest:
[see source text or glossary: Forest]
75) Vikasin (Vikasi, Vikashin):
[see source text or glossary: Vikasi]
[Note: The above list is limited to 75. Total glossary definitions available: 92]
Other Science Concepts:
Discover the significance of concepts within the article: �Study of Palasha Pushpa in Managing Vatarakta (Gouty Arthritis)�. Further sources in the context of Science might help you critically compare this page with similair documents:
Ayurveda, Vatarakta, Tridosha, Dravyaguna, Madhurarasa, Butea monosperma, Phytochemical, Signs and symptoms, Clinical study, Treatment duration, Clinical efficacy, Anti-inflammatory, Gouty arthritis, Subjective parameter, Objective parameter, Study results, Serum Uric Acid.